BIOMAT Database Logo BIOMAT Database Logo

Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients. 2013

M Klose, and D Marina, and M-L Hartoft-Nielsen, and O Klefter, and V Gavan, and L Hilsted, and A K Rasmussen, and U Feldt-Rasmussen
Department of Medical Endocrinology, PE2131, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. klose@rh.dk

BACKGROUND Thyroid dysfunction may have detrimental effects on patient outcomes. Few studies have assessed this issue in patients with secondary hypothyroidism. OBJECTIVE Our objective was to test the hypothesis that thyroid hormone status has an impact on cardiovascular risk factors in adult patients with hypopituitarism. METHODS This was a retrospective observational study (1993-2012) at a tertiary referral university hospital. METHODS All GH-deficient patients starting GH replacement (1993-2009) with measured free T4 (fT4) (n = 208). Baseline fT4 defined patients as TSH-sufficient and TSH-deficient (further divided into tertiles according to baseline fT4; first tertile had lowest fT4). METHODS Anthropometric (body mass index [BMI], waist circumference, total fat (fat mass) and lean body mass [LBM]) and biochemical (lipids and fasting plasma glucose) data were collected at baseline and a median 4.1 years after commencement of GH. RESULTS At baseline, fT4 was negatively associated with BMI and waist circumference, but positively with high-density lipoprotein, independent of age, gender, and IGF-I (SD score). Only first-tertile TSH-deficient patients had higher BMI (P = .02), fat mass (P = .03), total cholesterol (P = .05), triglycerides (P < .01), and waist circumference (P = .01), and lower high-density lipoprotein cholesterol (P = .03) as compared with TSH-sufficient patients. At follow-up, IGF-I, LBM, and plasma glucose had increased in all subgroups (P < .01). The change in fT4 (ΔfT4) (follow-up - baseline) was negatively correlated to ΔBMI, ΔLBM, Δtotal cholesterol, and Δlow-density lipoprotein cholesterol (all P < .05, adjusted for ΔIGF-I and ΔGH and hydrocortisone dose). The negative correlation to Δtotal cholesterol and Δlow-density lipoprotein cholesterol persisted only in first-tertile TSH-deficient patients. CONCLUSIONS This single-center study over a 20-year period has strengthened the importance of improved awareness of thyroid status and optimal thyroid replacement of hypopituitary patients to reduce cardiovascular risks in hypopituitary patients.

UI MeSH Term Description Entries
D007018 Hypopituitarism Diminution or cessation of secretion of one or more hormones from the anterior pituitary gland (including LH; FOLLICLE STIMULATING HORMONE; SOMATOTROPIN; and CORTICOTROPIN). This may result from surgical or radiation ablation, non-secretory PITUITARY NEOPLASMS, metastatic tumors, infarction, PITUITARY APOPLEXY, infiltrative or granulomatous processes, and other conditions. Adenohypophyseal Hyposecretion,Anterior Pituitary Hyposecretion Syndrome,Sheehan Syndrome,Simmonds Disease,Hyposecretion Syndrome, Anterior Pituitary,Hyposecretion, Adenohypophyseal,Pituitary Insufficiency,Postpartum Hypopituitarism,Postpartum Panhypopituitarism,Postpartum Pituitary Insufficiency,Sheehan's Syndrome,Simmonds' Disease,Disease, Simmonds,Hypopituitarism, Postpartum,Insufficiency, Pituitary,Panhypopituitarism, Postpartum,Pituitary Insufficiency, Postpartum,Sheehans Syndrome,Simmond's Disease,Syndrome, Sheehan,Syndrome, Sheehan's
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001823 Body Composition The relative amounts of various components in the body, such as percentage of body fat. Body Compositions,Composition, Body,Compositions, Body
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Klose, and D Marina, and M-L Hartoft-Nielsen, and O Klefter, and V Gavan, and L Hilsted, and A K Rasmussen, and U Feldt-Rasmussen
Central hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients.
October 2016, Endocrine,
M Klose, and D Marina, and M-L Hartoft-Nielsen, and O Klefter, and V Gavan, and L Hilsted, and A K Rasmussen, and U Feldt-Rasmussen
Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
January 2007, Clinical endocrinology,
M Klose, and D Marina, and M-L Hartoft-Nielsen, and O Klefter, and V Gavan, and L Hilsted, and A K Rasmussen, and U Feldt-Rasmussen
Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors.
February 2000, The Journal of clinical endocrinology and metabolism,
M Klose, and D Marina, and M-L Hartoft-Nielsen, and O Klefter, and V Gavan, and L Hilsted, and A K Rasmussen, and U Feldt-Rasmussen
Cardiovascular risk factors in hypopituitary GH-deficient adults.
November 2009, European journal of endocrinology,
M Klose, and D Marina, and M-L Hartoft-Nielsen, and O Klefter, and V Gavan, and L Hilsted, and A K Rasmussen, and U Feldt-Rasmussen
Classic cardiovascular risk factors improve in very elderly hypopituitary patients treated on standard hormone replacement in long term follow- up.
March 2021, Clinical diabetes and endocrinology,
M Klose, and D Marina, and M-L Hartoft-Nielsen, and O Klefter, and V Gavan, and L Hilsted, and A K Rasmussen, and U Feldt-Rasmussen
[Clinical features and risk factors of metabolic syndrome in adult hypopituitary patients].
September 2021, Zhonghua yi xue za zhi,
M Klose, and D Marina, and M-L Hartoft-Nielsen, and O Klefter, and V Gavan, and L Hilsted, and A K Rasmussen, and U Feldt-Rasmussen
Subclinical hypothyroidism and its association with cardiovascular risk factors.
January 2011, Clinical laboratory,
M Klose, and D Marina, and M-L Hartoft-Nielsen, and O Klefter, and V Gavan, and L Hilsted, and A K Rasmussen, and U Feldt-Rasmussen
[Cardiovascular risk factors in patients with subclinical hypothyroidism].
November 2007, Vojnosanitetski pregled,
M Klose, and D Marina, and M-L Hartoft-Nielsen, and O Klefter, and V Gavan, and L Hilsted, and A K Rasmussen, and U Feldt-Rasmussen
The metabolic consequences of thyroxine replacement in adult hypopituitary patients.
December 2012, Pituitary,
M Klose, and D Marina, and M-L Hartoft-Nielsen, and O Klefter, and V Gavan, and L Hilsted, and A K Rasmussen, and U Feldt-Rasmussen
Metabolic syndrome and its components in adult hypopituitary patients.
August 2020, Pituitary,
Copied contents to your clipboard!